LeMaitre Vascular Inc (LMAT) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Total Assets Chart for LeMaitre Vascular Inc
LeMaitre Vascular Inc (LMAT) total assets for FY2025 were USD 615.7M, a 11.6% change from FY2024. LeMaitre Vascular Inc's total assets grew from USD 12.2M in 2001 to USD 615.7M in 2025 (4962.4% over 24 years). Total assets compound annual growth rate: 5-year CAGR of 19.5%, 10-year CAGR of 21.1%, 20-year CAGR of 17.4%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.85B
- Implied Share Price
- $80.82
- Enterprise Value
- $1.66B
- Revenue (TTM)
- $262.43M
- EBITDA
- $83.02M
- Profit Margin
- 25.02%
- Trailing P/E
- 28.36
- Forward P/E
- 25.58
- Price/Book (MRQ)
- 4.38
- Price/Sales (TTM)
- 7.04
- EV/EBITDA
- 16.49
- EV/Revenue
- 6.31
- Dividend Yield
- 1.08%
- Book Value
- $18.38
- Free Cash Flow (FY2025)
- $74.47M
- Free Cash Flow Yield
- 4.03%
Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.